Omega-3 and Effexor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omega-3 (cod liver oil) and Effexor (venlafaxine hydrochloride). Common drug interactions include fatigue among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Omega-3 and Effexor. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Omega-3?

Omega-3 has active ingredients of cod liver oil. It is often used in high blood cholesterol. eHealthMe is studying from 3,482 Omega-3 users. Check the latest studies of Omega-3.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.



On Jul, 12, 2026

33 people who take Omega-3 and Effexor together, and have interactions are studied.

Omega-3 and Effexor drug interactions.

What are the common drug interactions of Omega-3 and Effexor, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Breast cancer stage iii
  3. Headache (pain in head)
  4. Infusion related reaction
  5. Asthenia (weakness)
  6. Body temperature increased
  7. Drug ineffective
  8. Nephrolithiasis (calculi in the kidneys)
  9. Pain
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

  1. Blood creatinine increased
  2. Blood pressure increased
  3. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  4. Suicidal ideation
  5. Cough
  6. Dyspnoea (difficult or laboured respiration)
  7. Headache (pain in head)
  8. Insomnia (sleeplessness)
  9. Lacrimation increased
  10. Lyme disease (a bacterial infection that is spread to humans by infected ticks)

What are the common drug interactions of Omega-3 and Effexor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Breast cancer stage iii
  2. Breast cancer metastatic
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Suicidal ideation

40-49:

  1. Lyme disease (a bacterial infection that is spread to humans by infected ticks)

50-59:

  1. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  2. Sleep disorder
  3. Allergy to animal
  4. Anaemia (lack of blood)
  5. Botulism (food poisoning caused by botulinum growing)
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
  8. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  9. Diplopia (double vision)
  10. Discomfort

60+:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Breast cancer stage iii
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cough
  8. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  9. Dyspnoea (difficult or laboured respiration)
  10. Dysstasia (difficulty in standing)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 6 people, 18.18%
  2. Pain: 6 people, 18.18%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 15.15%
  4. Immunodeficiency Common Variable: 5 people, 15.15%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 12.12%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 12.12%
  7. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 12.12%
  8. Breast Cancer: 3 people, 9.09%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 9.09%
  10. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Omega-3 and Effexor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omega-3 and Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omega-3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omega-3 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cod liver oil and venlafaxine hydrochloride (the active ingredients of Omega-3 and Effexor, respectively), and Omega-3 and Effexor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: